Skip to main content

Global Spatial Genomics and Transcriptomics Market

 

Non-communicable diseases (NCDS), such as cardiovascular disorders accounts for 17.9 million deaths in 2018, followed by cancers which accounted for 9.0 million deaths, respiratory diseases with 3.9 million deaths, and diabetes resulted in 1.6 million deaths. Other than cancer, infectious diseases, such as HIV/AIDS, tuberculosis, malaria, and HPV, are also responsible for the increasing death rates, especially in developing countries. In 2018, HIV accounted for 770,000 deaths globally, and more than 1.7 million people were newly infected. In 2018, there were an estimated 228 million cases of malaria worldwide.

 View BIS Research Report: Spatial Genomics and Transcriptomics Market

According to the World Health Organization, there is a great disparity in the life expectancy rate in low-income countries than in high-income countries, such as Australia, Canada, the U.S., and the U.K. In 2016, life expectancy was 18.1 years lower in low-income countries (62.7 years) than in high-income countries (80.8 years). The extension of life expectancy and the ageing of populations globally has resulted in the increased prevalence of many noncommunicable, chronic, progressive conditions including neurological disorders.

 

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...